1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Porphyria (Erythropoietic Protoporphyri) Global Clinical Trials Review, H2, 2015

Porphyria (Erythropoietic Protoporphyri) Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Porphyria (Erythropoietic Protoporphyri) Global Clinical Trials Review, H2, 2015" provides an overview of Porphyria (Erythropoietic Protoporphyri) clinical trials scenario. This report provides top line data relating to the clinical trials on Porphyria (Erythropoietic Protoporphyri). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Porphyria (Erythropoietic Protoporphyri) Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Porphyria (Erythropoietic Protoporphyri) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Porphyria (Erythropoietic Protoporphyri) to Genetic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials 23
Prominent Drugs 24
Latest Clinical Trials News on Porphyria (Erythropoietic Protoporphyri) 25
Jul 02, 2015: New England Journal of Medicine publishes pivotal Phase III SCENESSE studies 25
Jul 01, 2015: Treatment Reduces Symptoms in Syndrome that Causes Extreme Light Sensitivity 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Clinuvel Pharmaceuticals Limited 27
Clinical Trial Overview of Clinuvel Pharmaceuticals Limited 27
Digna Biotech, S.L. 28
Clinical Trial Overview of Digna Biotech, S.L. 28
Zymenex A/S 29
Clinical Trial Overview of Zymenex A/S 29
uniQure N.V. 30
Clinical Trial Overview of uniQure N.V. 30
Novartis AG 31
Clinical Trial Overview of Novartis AG 31
CPR Pharma Services Pty Ltd 32
Clinical Trial Overview of CPR Pharma Services Pty Ltd 32
Alnylam Pharmaceuticals, Inc. 33
Clinical Trial Overview of Alnylam Pharmaceuticals, Inc. 33
Clinical Trial Overview of Top Institutes / Government 34
National Center for Research Resources 34
Clinical Trial Overview of National Center for Research Resources 34
Assistance Publique - Hopitaux de Paris 35
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 35
FDA Office of Orphan Products Development 36
Clinical Trial Overview of FDA Office of Orphan Products Development 36
Guy's and St Thomas' NHS Foundation Trust 37
Clinical Trial Overview of Guy's and St Thomas' NHS Foundation Trust 37
Mayo Clinic 38
Clinical Trial Overview of Mayo Clinic 38
The University of Utah 39
Clinical Trial Overview of The University of Utah 39
University of Texas at Galveston 40
Clinical Trial Overview of University of Texas at Galveston 40
University of Texas Medical Branch at Galveston 41
Clinical Trial Overview of University of Texas Medical Branch at Galveston 41
University of Texas Southwestern Medical Center at Dallas 42
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 42
Five Key Clinical Profiles 43
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 70

List of Tables
Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Proportion of Porphyria (Erythropoietic Protoporphyri) to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13
Porphyria (Erythropoietic Protoporphyri) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Porphyria (Erythropoietic Protoporphyri) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials by Phase, 2015* 16
Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17
Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 20
Porphyria (Erythropoietic Protoporphyri) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 21
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 22
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 23
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 24
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Clinuvel Pharmaceuticals Limited, 2015* 27
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Digna Biotech, S.L., 2015* 28
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Zymenex A/S, 2015* 29
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by uniQure N.V., 2015* 30
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 31
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by CPR Pharma Services Pty Ltd, 2015* 32
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alnylam Pharmaceuticals, Inc., 2015* 33
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2015* 34
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 35
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by FDA Office of Orphan Products Development, 2015* 36
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Guy's and St Thomas' NHS Foundation Trust, 2015* 37
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 38
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2015* 39
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas at Galveston, 2015* 40
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Medical Branch at Galveston, 2015* 41
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2015* 42

List of Figures
Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Proportion of Porphyria (Erythropoietic Protoporphyri) to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13
Porphyria (Erythropoietic Protoporphyri) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Porphyria (Erythropoietic Protoporphyri) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16
Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17
Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 20
Porphyria (Erythropoietic Protoporphyri) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 21
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 22
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 23
Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 24
GlobalData Methodology 68

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.